Novartis Announce Tasigna® Approved by FDA for Chronic Myeloid Leukemia (CML)
On October 29th Novartis announced that "been approved in the US as a new anti-cancer therapy for certain patients with a life-threatening form of leukemia who are resistant or intolerant to prior treatment including Glivec® (imatinib)*, an established treatment standard and a leading Novartis medicine....
Read More and Discuss
Showing entries 1 to 1 of 1
|
|
Discussion